Randomized, double-blind, placebo-controlled trial of oral sirolimus for restenosis prevention in patients with in-stent restenosis: the Oral Sirolimus to Inhibit Recurrent In-stent Stenosis (OSIRIS) trial (Q45012607)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Randomized, double-blind, placebo-controlled trial of oral sirolimus for restenosis prevention in patients with in-stent restenosis: the Oral Sirolimus to Inhibit Recurrent In-stent Stenosis (OSIRIS) trial
scientific article

    Statements

    Randomized, double-blind, placebo-controlled trial of oral sirolimus for restenosis prevention in patients with in-stent restenosis: the Oral Sirolimus to Inhibit Recurrent In-stent Stenosis (OSIRIS) trial (English)
    Jörg Hausleiter
    Michael Vogeser
    Dietlind Zohlnhöfer
    Helmut Schühlen
    Christoph Goos
    Jürgen Pache
    Franz Dotzer
    Gisela Pogatsa-Murray
    Josef Dirschinger
    Uwe Heemann
    OSIRIS Investigators
    9 August 2004
    790-795

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit